Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)

Publication | Open Access

DOI Full Paper Access

129

Citations

References

2006

Year

Jarir At Thobari, Folkert W. Asselbergs, Cornelis Boersma, Robin de Vries, Hans L. Hillege, Wiek H. van Gilst, Ron T. Gansevoort, Paul E. de Jong, Lolkje T.W. de Jong‐van den Berg, Maarten J. Postma

Clinical Therapeutics

Pharmacoeconomic AnalysisHemodialysisUrologyRenal FunctionHealth EconomicsHealth PolicyMedicineCardiovascular DiseasePrevend ItPharmacoeconomicsVascular Endstage DiseasePublic HealthChronic Kidney DiseaseRenal PharmacologyNephrology